6-K ·Filed Jun 29, 2026

TAK

TAKEDA PHARMACEUTICAL CO LTD
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001395064-26-000189
Notable filing: 6-K
Actionable Insight • Neutral

No immediate trading implications. Monitor upcoming earnings or business development filings for material updates.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
TAK ▲ +18.59% at T+60d
NEUTRAL call ✓ call won +18.59% · α vs SPY +14.20% · entry $15.98 → $18.95
Entry anchored
Jun 26, 03:59 PM ET
via exchange tick
T+1d
+0.31%
call +0.31% · α -0.47%
$16.03
settled 3mo ago
T+5d
+5.69%
call +5.69% · α +4.31%
$16.89
settled 3mo ago
T+20d
+7.88%
call +7.88% · α +8.16%
$17.24
settled 2mo ago
T+60d
+18.59%
call +18.59% · α +14.20%
$18.95
settled 9d ago

Price Chart

Loading chart...

Executive Summary

Takeda filed a 6-K furnishing an English translation of its updated Articles of Incorporation, effective June 29, 2026. The amendments are routine governance updates with no financial or operational impact.

Key Facts

  • Filed updated Articles of Incorporation on June 29, 2026.
  • No changes to authorized shares, business purpose, or governance structure material to shareholders.
  • Routine administrative filing for a foreign private issuer.

Financial Impact

None; no financial figures disclosed.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
68% bullish (19 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001395064-26-000189
Document: form6k_062926.htm0001395064-26-000189
Document: 0001395064-26-000189-index-headers.html0001395064-26-000189
Document: 0001395064-26-000189-index.html0001395064-26-000189
Document: 0001395064-26-000189.txt0001395064-26-000189
13 reports for TAK
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for TAK — sortable, filterable
TypeNow
Sep 14, 2026
18d ago
6-K
BULLISH ★ 7/10
$18.60 $18.89▲ +1.56%▲ +1.45%$17.86 (−3.98%)
Aug 21, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$18.18 $18.03▼ −0.83%▼ −1.30%$17.86 (−1.76%)
Aug 19, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$18.34 $18.23▼ −0.60%▼ −0.21%$17.86 (−2.62%)
Aug 14, 2026
7w ago
Court Ruling
NEUTRAL ★ 4/10
$17.63 $18.18▲ +3.12%▲ +4.49%$17.86 (+1.30%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$17.39 $18.13▲ +4.26%▲ +6.22%$17.86 (+2.70%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$17.39 $18.13▲ +4.26%▲ +6.22%$17.86 (+2.70%)
Jul 9, 2026
12w ago
6-K
NEUTRAL ★ 2/10
$16.61 $16.73▲ +0.72%▲ +0.85%$17.86 (+7.53%)
Jul 8, 2026
12w ago
6-K
NEUTRAL ★ 2/10
$16.75 $16.39▼ −2.15%▼ −3.01%$17.86 (+6.63%)
Jul 6, 2026
12w ago
3
NEUTRAL ★ 2/10
$16.89 $16.56▼ −1.95%▼ −2.44%$17.86 (+5.74%)
Jun 29, 2026
13w ago
6-K
NEUTRAL ★ 2/10
$15.98 $16.89▲ +5.69%▲ +4.31%$17.86 (+11.76%)
Showing 10 of 13

US Market Status

Market Closed — Opens Mon (64h 59m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access